期刊文献+

头孢噻呋钠-壳聚糖纳米粒的制备及相关性质的研究 被引量:3

Preparation and characterization of ceftiofur sodium-chitosan nanoparticles
原文传递
导出
摘要 为了延长头孢噻呋钠的作用时间,采用离子交联法制备头孢噻呋钠-壳聚糖纳米粒,研究其形态、粒径、载药量、包封率和体外释药特性。结果显示,经优化工艺所得的纳米粒形态规整,近圆形,平均粒径为179.4±39.5nm,平均包封率为84.31%±2.53%,平均载药量为6.69%±0.18%。体外释放试验表明,原料药在放入释放介质后第4小时释放率达到90%以上,而纳米粒在此时药物仅释放60%。结果表明,该纳米粒制备工艺可行,对头孢噻呋钠具有明显的缓释效果。 To prolong the action time of ceftiofur sodium, ceftiofur sodium-chitosan nanoparticle(CNP) were prepared by ionic crosslinking method. Morphology, particle size and distribution, encapsulation efficiency and drug loading rate were investigated. In result, the appearance of prepared CNP was regular with the diameter being of 179.4±39.5 nm. The encapsulation efficiency and drug-loading rate were 84.31% ±2.53 % and 6.69 %±0.18 % respectively. The in vitro release experiment showed that the ceftiofur sodium was released above 90% at 4 h post-treatment,meanwhile only 60% was released from CNP. In conclusion, the CNP preparation procedure is feasible and CNP have obvious sustained-release effect.
出处 《中国兽医科学》 CAS CSCD 北大核心 2012年第6期637-641,共5页 Chinese Veterinary Science
基金 教育部"长江学者和创新团队发展计划"创新团队项目(IRT0848)
关键词 头孢噻呋钠 壳聚糖 纳米粒 质量评价 ceftiofur sodium chitosan nanoparticle quality evaluation
  • 相关文献

参考文献5

二级参考文献21

  • 1付春梅,刘三康,李章万,钱广生.穿琥宁原料药及其注射液的有关物质检查和含量测定方法研究[J].药物分析杂志,2005,25(2):157-159. 被引量:7
  • 2王琳,蔡宝昌,李伟东,邓旭坤.马钱子碱长循环脂质体的制备和质量评价[J].中国药学杂志,2006,41(18):1397-1400. 被引量:23
  • 3董方田 陈有信 张承芬 见:张承芬 主编.玻璃体疾患[A].见:张承芬,主编.眼底病学.第1版[C].北京:人民卫生出版社,1998.357-358.
  • 4Rachal WF,Burton TC.Changing concepts of failures after retinal detachment surgery.Arch Ophthalmol,1979,97:480-483
  • 5Boisdron M,Menei PH,Benoit JP.Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancerdrug carriers.J Pharm Pharmacol,1995,47:108-111
  • 6Li JK,Wang N,Wu XS.A novel biodegradable system based ongelatin nanoparticles and peptide drug delivery.J Pharm Sci,1997,86:891-894
  • 7Prior S,Gamazo C,Irache JM.Gentamycin encapsulation in PLA/PLGA microspheres in view of treating Brucella infection.International Journal of Pharmaceutics,2000,196:115-118
  • 8Stern WH,Lewis GP,Erickson PA,et al.Fluorouracil therapy forproliferative vitreoretinopathy after vitrectomy.Am J Ophthalmol,1983,96:33-42
  • 9Anas El Aneed.An overview of current delivery systems in cancer gene therapy[J].Journal of Controlled Release ,2004,94:1
  • 10Curotto E,Aros F.Quantitative determination of chitosan and the percentage of free amino group[J].Analytical Biochemistry,1993, 211(2):240

共引文献95

同被引文献35

  • 1刘兴国,周洪琪,宋理平.低分子壳聚糖对罗非鱼的肝脂代谢和饲料利用效率的影响研究[J].海洋水产研究,2004,25(5):42-46. 被引量:14
  • 2郝英魁,杨学东.载药壳聚糖纳米粒的研究进展[J].中国药学杂志,2005,40(17):1292-1295. 被引量:30
  • 3中国药典[S].2010年版.一部.39-40,189,32.
  • 4包文芳,吴维春,李葆华.抗疲劳药用植物红景天[M].北京:人民军医出版社,2004.
  • 5Garcia-Fuentes M, Alonso M J. Chitosan-based drugnanocarriers: Where do we stand? [J]. J ControlledRelease, 2012, 161(2): 496-504.
  • 6Trapani A, Sitterberg J,Bakowsky U, et al. The potentialof glycol chitosan nanoparticles as carrier for low watersoluble drugs [J]. IntJPharm, 2009, 375(1/2): 97-106.
  • 7Chung Y, Chen C. Antibacterial characteristics and activity of acid-soluble ehitosan[J]. Bioresource Teehnology. 2008, 99: 2806-2814.
  • 8Tang Z, Yin Y. E{feets of dietary supplementation of chltosan and galaeto-mannan oligosaceharide on serum parameters and the insulin-like growth factor-1 mRNA expression in early- weaned piglets[J]. Domestic Animal Endocrinology, 2005, 28 (4) :430-441.
  • 9Chung Y C, Wang H L, Chen Y M, et al. Effect of abiotic factors on the antibacterial activity of chitosan against water borne pathogents[J]. Bioresource Technology, 2003, 88(3) : 179-184.
  • 10崔艳梅,娄安如,赵长琦.红景天属植物化学成分及药理作用研究进展[J].北京师范大学学报(自然科学版),2008,44(3):328-333. 被引量:53

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部